
Taiwo Oladapo
Examiner (ID: 13527, Phone: (571)270-3723 , Office: P/1771 )
| Most Active Art Unit | 1771 |
| Art Unit(s) | 1797, 1771 |
| Total Applications | 1276 |
| Issued Applications | 617 |
| Pending Applications | 137 |
| Abandoned Applications | 548 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9662315
[patent_doc_number] => 08809291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-19
[patent_title] => 'Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma'
[patent_app_type] => utility
[patent_app_number] => 13/252148
[patent_app_country] => US
[patent_app_date] => 2011-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 16369
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13252148
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/252148 | Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma | Oct 2, 2011 | Issued |
Array
(
[id] => 7742312
[patent_doc_number] => 20120020984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Genetic Markers for Predicting Responsiveness to Combination Therapy'
[patent_app_type] => utility
[patent_app_number] => 13/249148
[patent_app_country] => US
[patent_app_date] => 2011-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 30045
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20120020984.pdf
[firstpage_image] =>[orig_patent_app_number] => 13249148
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/249148 | Genetic markers for predicting responsiveness to combination therapy | Sep 28, 2011 | Issued |
Array
(
[id] => 8981588
[patent_doc_number] => 08512701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration'
[patent_app_type] => utility
[patent_app_number] => 13/248904
[patent_app_country] => US
[patent_app_date] => 2011-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 22763
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13248904
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/248904 | Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration | Sep 28, 2011 | Issued |
Array
(
[id] => 7733887
[patent_doc_number] => 20120016111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'Compositions for the treatment of cancer, and methods for testing and using the same'
[patent_app_type] => utility
[patent_app_number] => 13/241683
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12127
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20120016111.pdf
[firstpage_image] =>[orig_patent_app_number] => 13241683
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/241683 | Compositions for the treatment of cancer, and methods for testing and using the same | Sep 22, 2011 | Abandoned |
Array
(
[id] => 7817469
[patent_doc_number] => 20120064089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES FOR THE PREVENTION AND TREATMENT OF CANCER AND CANCER CELL MIGRATION'
[patent_app_type] => utility
[patent_app_number] => 13/233769
[patent_app_country] => US
[patent_app_date] => 2011-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 19412
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20120064089.pdf
[firstpage_image] =>[orig_patent_app_number] => 13233769
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/233769 | ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES FOR THE PREVENTION AND TREATMENT OF CANCER AND CANCER CELL MIGRATION | Sep 14, 2011 | Abandoned |
Array
(
[id] => 8221220
[patent_doc_number] => 20120135424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'MER DIAGNOSTIC AND THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/230005
[patent_app_country] => US
[patent_app_date] => 2011-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 30179
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13230005
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/230005 | MER DIAGNOSTIC AND THERAPEUTIC AGENTS | Sep 11, 2011 | Abandoned |
Array
(
[id] => 9983802
[patent_doc_number] => 09029516
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-12
[patent_title] => 'Antibodies and molecules derived therefrom that bind to STEAP-1 proteins'
[patent_app_type] => utility
[patent_app_number] => 13/199539
[patent_app_country] => US
[patent_app_date] => 2011-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 88
[patent_no_of_words] => 90276
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13199539
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/199539 | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins | Aug 30, 2011 | Issued |
Array
(
[id] => 10919686
[patent_doc_number] => 20140322705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'Cancer diagnostic and cancer therapeutic'
[patent_app_type] => utility
[patent_app_number] => 13/817687
[patent_app_country] => US
[patent_app_date] => 2011-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 39589
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817687
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/817687 | Cancer diagnostic and cancer therapeutic | Aug 18, 2011 | Abandoned |
Array
(
[id] => 9107031
[patent_doc_number] => 20130280163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Antibodies and molecules derived therefrom that bind to STEAP-1 proteins'
[patent_app_type] => utility
[patent_app_number] => 13/136897
[patent_app_country] => US
[patent_app_date] => 2011-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 87
[patent_no_of_words] => 89888
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13136897
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/136897 | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins | Aug 11, 2011 | Issued |
Array
(
[id] => 7580251
[patent_doc_number] => 20110294134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'METHODS AND KITS FOR DETERMINING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/204737
[patent_app_country] => US
[patent_app_date] => 2011-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17304
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294134.pdf
[firstpage_image] =>[orig_patent_app_number] => 13204737
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/204737 | METHODS AND KITS FOR DETERMINING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER | Aug 7, 2011 | Abandoned |
Array
(
[id] => 7651825
[patent_doc_number] => 20110301094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'NEW TUMOR SUPPRESSOR GENE, P28ING5'
[patent_app_type] => utility
[patent_app_number] => 13/197595
[patent_app_country] => US
[patent_app_date] => 2011-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 30138
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301094.pdf
[firstpage_image] =>[orig_patent_app_number] => 13197595
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/197595 | NEW TUMOR SUPPRESSOR GENE, P28ING5 | Aug 2, 2011 | Abandoned |
Array
(
[id] => 9073914
[patent_doc_number] => 08551490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-08
[patent_title] => 'Genetic products differentially expressed in tumors and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/184719
[patent_app_country] => US
[patent_app_date] => 2011-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20654
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13184719
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/184719 | Genetic products differentially expressed in tumors and use thereof | Jul 17, 2011 | Issued |
Array
(
[id] => 7766031
[patent_doc_number] => 20120034158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis corresponding compositions and kits'
[patent_app_type] => utility
[patent_app_number] => 13/067998
[patent_app_country] => US
[patent_app_date] => 2011-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7798
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034158.pdf
[firstpage_image] =>[orig_patent_app_number] => 13067998
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/067998 | Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis corresponding compositions and kits | Jul 13, 2011 | Abandoned |
Array
(
[id] => 7670600
[patent_doc_number] => 20110319869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'HUMAN CYTOTOXIC T-LYMPHOCYTE EPITOPE AND ITS AGONIST EPITOPE FROM THE NON-VARIABLE NUMBER OF TANDEM REPEAT SEQUENCE OF MUC-1'
[patent_app_type] => utility
[patent_app_number] => 13/176341
[patent_app_country] => US
[patent_app_date] => 2011-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 38391
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13176341
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/176341 | Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 | Jul 4, 2011 | Issued |
Array
(
[id] => 7669102
[patent_doc_number] => 20110318371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'Novel serpentine transmembrane antigens expressed in human cancers and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/134650
[patent_app_country] => US
[patent_app_date] => 2011-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 21340
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13134650
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/134650 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Jun 12, 2011 | Issued |
Array
(
[id] => 7487439
[patent_doc_number] => 20110236383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'Protein Formulation'
[patent_app_type] => utility
[patent_app_number] => 13/156113
[patent_app_country] => US
[patent_app_date] => 2011-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17477
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236383.pdf
[firstpage_image] =>[orig_patent_app_number] => 13156113
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/156113 | Protein Formulation | Jun 7, 2011 | Abandoned |
Array
(
[id] => 8865596
[patent_doc_number] => 20130149298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin'
[patent_app_type] => utility
[patent_app_number] => 13/154076
[patent_app_country] => US
[patent_app_date] => 2011-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 185
[patent_figures_cnt] => 185
[patent_no_of_words] => 110525
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13154076
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/154076 | Compositions and methods for the treatment of tumor of hematopoietic origin | Jun 5, 2011 | Issued |
Array
(
[id] => 8963115
[patent_doc_number] => 20130202717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'MATERIALS AND METHODS FOR DIAGNOSING AND PREDICTING THE COURSE OF PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/700777
[patent_app_country] => US
[patent_app_date] => 2011-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8960
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700777
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/700777 | MATERIALS AND METHODS FOR DIAGNOSING AND PREDICTING THE COURSE OF PROSTATE CANCER | May 31, 2011 | Abandoned |
Array
(
[id] => 7731517
[patent_doc_number] => 20120014942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF MALIGNANT DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/116319
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18706
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20120014942.pdf
[firstpage_image] =>[orig_patent_app_number] => 13116319
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/116319 | Method for the diagnosis and prognosis of malignant diseases | May 25, 2011 | Issued |
Array
(
[id] => 6091067
[patent_doc_number] => 20110218329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES'
[patent_app_type] => utility
[patent_app_number] => 13/105152
[patent_app_country] => US
[patent_app_date] => 2011-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32346
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218329.pdf
[firstpage_image] =>[orig_patent_app_number] => 13105152
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/105152 | ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES | May 10, 2011 | Abandoned |